These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9924927)

  • 1. Leukemic pleural effusion in B-cell prolymphocytic leukemia.
    Andrieu V; Encaoua R; Carbon C; Couvelard A; Grange MJ
    Hematol Cell Ther; 1998 Dec; 40(6):275-8. PubMed ID: 9924927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody.
    Mourad YA; Taher A; Chehal A; Shamseddine A
    Ann Hematol; 2004 May; 83(5):319-21. PubMed ID: 15060751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment by ranimustine (MCNU) of a patient with B-cell prolymphocytic leukemia (B-PLL)].
    Wake A; Yamasaki Y; Ogawa R; Mori N; Nagata K; Nakata K; Misago M; Izumi Y; Fujita K; Oda S
    Rinsho Ketsueki; 1993 Nov; 34(11):1464-9. PubMed ID: 8254909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
    Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
    Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia.
    Ogasawara T; Narita C; Kawauchi K
    Leuk Res; 2007 Mar; 31(3):403-6. PubMed ID: 16620970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Prolymphocytic leukemia: a case study.
    Roberts JC; Roberts GH
    Clin Lab Sci; 2001; 14(4):233-7. PubMed ID: 11760820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
    Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
    [No Abstract]   [Full Text] [Related]  

  • 9. Current treatment options in prolymphocytic leukemia.
    Robak T; Robak P
    Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukemic B-cell colony formation in patients with B-cell prolymphocytic leukemia].
    Ishiyama T; Akimoto Y; Ueno H; Yajima K; Tomoyasu S; Tsuruoka N; Wakabayashi Y
    Rinsho Ketsueki; 1993 Mar; 34(3):301-6. PubMed ID: 8479081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.
    Loria MP; Dell'Osso A; Grande M; Dambra P; D'Oronzio L; Crollo R; Lasaracina E; Lucivero G
    Eur J Histochem; 1997; 41 Suppl 2():29-30. PubMed ID: 9859769
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
    Kantarjian HM; Childs C; O'Brien S; Huh Y; Beran M; Schachner J; Koller C; Keating MJ
    Am J Med; 1991 Feb; 90(2):223-8. PubMed ID: 1996592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
    Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
    Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion.
    Shimoni A; Shvidel L; Shtalrid M; Klepfish A; Berrebi A
    Am J Hematol; 1998 Dec; 59(4):316-8. PubMed ID: 9840914
    [No Abstract]   [Full Text] [Related]  

  • 15. Richter's syndrome in a patient with B prolymphocytic leukemia.
    Grange MJ; Andrieu V; Chemlal K
    Haematologica; 1999 May; 84(5):461-641. PubMed ID: 10329926
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin and gingival lesions in a young woman with B-prolymphocytic leukemia (B-PLL).
    Panteli K; Bai M; Basioukas K; Vartholomatos G; Zioga K; Bourantas KL
    J Exp Clin Cancer Res; 2001 Sep; 20(3):447-9. PubMed ID: 11718228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
    Doorduijn JK; Michiels JJ
    Leukemia; 1994 Aug; 8(8):1439. PubMed ID: 8057685
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
    Tanvetyanon T; Elmishad AG; Carbone M
    Anticancer Res; 2005; 25(1B):429-33. PubMed ID: 15816607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained response of refractory prolymphocytic leukemia to fludarabine.
    Sporn JR
    Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.